It is derived from glutamic acid, cysteine, and glycine
Honorable Mention: Mounjaro (tirzepatide) Indication(s): Type 2 diabetes, chronic weight management Manufacturer(s): Eli Lilly 2024 Sales (USD): $11.54 billion 2025 Outlook: While Mounjaro itself is not approved for weight loss, it drove significant off-label use before Zepbounds launch and helped set the stage for the obesity-focused branding strategy that now powers Lillys market dominance
Regina Fink-Puches (Generalsekretrin)
doi: 10.1016/S1474-4422(13)70051-6 9
Our supportive, step-by-step approach empowers you to feel better, stay motivated, and make meaningful progress without feeling overwhelmed
The program is intentionally designed to surround patients with continuous, specialized support before and long after surgery a level of care that distinguishes it as one of the most comprehensive weight loss programs in Southern California